Volume: | 116,179 |
Day Range: | 0.9012 - 0.9428 |
Bid: | 0.9151 |
Ask: | 0.936 |
Last Trade Time: | 3:16:34 PM EST |
Total Trades: | 297 |
Recent CLSD News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2025 09:30:07 PM
- Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye • GlobeNewswire Inc. • 12/19/2024 12:05:00 PM
- Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States • GlobeNewswire Inc. • 11/25/2024 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:10:09 PM
- Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema • GlobeNewswire Inc. • 11/07/2024 02:05:00 PM
- Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference • GlobeNewswire Inc. • 11/06/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 09:15:04 PM
- Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors • GlobeNewswire Inc. • 11/04/2024 12:05:00 PM
- Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024 • GlobeNewswire Inc. • 10/31/2024 11:05:00 AM
- Clearside Biomedical’s Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting • GlobeNewswire Inc. • 10/22/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/09/2024 11:55:13 AM
- Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes • GlobeNewswire Inc. • 10/09/2024 10:30:00 AM
- Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD • GlobeNewswire Inc. • 08/27/2024 11:05:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:15:08 PM
- Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/08/2024 11:05:00 AM
- Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Clearside Biomedical’s Partner Arctic Vision Reports Positive Topline Results from Phase 3 Clinical Trial of ARCATUS® for Suprachoroidal Use in Uveitic Macular Edema Patients in China • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 11:55:18 AM
- Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET • GlobeNewswire Inc. • 07/22/2024 04:00:00 PM
- Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board • GlobeNewswire Inc. • 07/11/2024 11:05:00 AM
- Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery • GlobeNewswire Inc. • 06/27/2024 11:05:00 AM
- Clearside Biomedical’s Leadership in Suprachoroidal Delivery Featured in Multiple Presentations at the Clinical Trials at the Summit Meeting • GlobeNewswire Inc. • 06/12/2024 11:05:00 AM
FEATURED Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM
Avant Technologies and Ainnova Begin Implementing and Testing Advanced AI Algorithms for Early Detection of Additional Diseases • AVAI • Jan 16, 2025 8:00 AM
VOCODIA HOLDINGS INC. (OTCMKTS: VHAI) and TRACCOM INC. (OTCMKTS: TRCC) have signed an MOU to form a Joint Venture that will Revolutionize Event Monitoring with Narrative AI • VHAI • Jan 15, 2025 2:53 PM